BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2112659)

  • 1. [Disseminated intravascular coagulation (DIC) after artificial valve replacement: especially tricuspid regurgitation].
    Satokawa H; Iwaya F; Igari T; Abe T; Hagiwara K; Tanji M; Watanabe M; Midorikawa H; Sato Y; Takase S
    Kyobu Geka; 1990 Apr; 43(4):271-5. PubMed ID: 2112659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gabexate as a therapy for disseminated intravascular coagulation.
    Umeki S; Adachi M; Watanabe M; Yaji S; Soejima R
    Arch Intern Med; 1988 Jun; 148(6):1409-12. PubMed ID: 3132124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hemostatic changes after artificial valve replacement--especially tricuspid regurgitation].
    Satokawa H
    Nihon Kyobu Geka Gakkai Zasshi; 1990 Aug; 38(8):1241-7. PubMed ID: 2230377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of FOY therapy for DIC or pre-DIC associated with neurosurgical disease].
    Wakui K; Takemae T; Kobayashi S
    No Shinkei Geka; 1990 Jul; 18(7):609-17. PubMed ID: 2118601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of antithrombin and gabexate mesilate on disseminated intravascular coagulation: a preliminary study.
    Nishiyama T; Kohno Y; Koishi K
    Am J Emerg Med; 2012 Sep; 30(7):1219-23. PubMed ID: 22204993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Disseminated intravascular coagulation (DIC) following open heart surgery and great vessel surgery. The result of early administration of gabexate mesilate (FOY)].
    Chihara K; Akiyama F; Shinozaki T; Shimamoto M; Takahashi K; Imura H; Yamazaki F; Kawarazaki S
    Kyobu Geka; 1984 Aug; 37(8):606-13. PubMed ID: 6438381
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of disseminated intravascular coagulation (DIC) or pre-DIC with gabexate mesilate (FOY)].
    Wada H; Suzuki H; Mori Y; Deguchi A; Oukubo I; Tsuda M; Tanaka I; Deguchi K; Shirakawa S; Minami N
    Nihon Gan Chiryo Gakkai Shi; 1988 Jan; 23(1):67-73. PubMed ID: 3132518
    [No Abstract]   [Full Text] [Related]  

  • 8. Optimal surgical management of severe tricuspid regurgitation in cardiac transplant patients.
    Filsoufi F; Salzberg SP; Anderson CA; Couper GS; Cohn LH; Adams DH
    J Heart Lung Transplant; 2006 Mar; 25(3):289-93. PubMed ID: 16507421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of disseminated intravascular coagulation with gabexate mesilate.
    Tamaki S; Wada H; Hiyoyama K; Shimura M; Minamikawa K; Wakita Y; Nakase T; Ohiwa M; Kaneko T; Iwasaki E
    Clin Ther; 1993; 15(6):1076-84. PubMed ID: 8111805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and treatment of disseminated intravascular coagulation associated with neurosurgical diseases; a proposal of a new scoring system for DIC].
    Kameyama S; Fujii Y; Koike T; Tanaka R; Takahashi H
    No Shinkei Geka; 1992 Jul; 20(7):749-55. PubMed ID: 1630565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disseminated intravascular coagulation after hepatic resection.
    Tsuzuki T; Toyama K; Nakayasu K; Iida S; Ueda M; Toizumi A
    Surgery; 1990 Feb; 107(2):172-6. PubMed ID: 2154054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies.
    Minakata D; Fujiwara SI; Ikeda T; Kawaguchi SI; Toda Y; Ito S; Ochi SI; Nagayama T; Mashima K; Umino K; Nakano H; Yamasaki R; Morita K; Kawasaki Y; Sugimoto M; Yamamoto C; Ashizawa M; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Ohmori T; Kanda Y
    Int J Hematol; 2019 Feb; 109(2):141-146. PubMed ID: 30536180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective comparative study of recombinant human thrombomodulin and gabexate mesilate in sepsis-induced disseminated intravascular coagulation patients.
    Takazono T; Nakamura S; Imamura Y; Yoshioka S; Miyazaki T; Izumikawa K; Sawai T; Matsuo N; Yanagihara K; Suyama N; Kohno S
    J Infect Chemother; 2014 Aug; 20(8):484-8. PubMed ID: 24855912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of FOY on DIC patients associated with hematological neoplastic disorders. Hanshin Cooperative Study Group of Hematological Disorders].
    Taniguchi N; Kitani T; Kawagoe H; Horiuchi A; Masaoka T; Yasunaga K; Okamoto Y; Ohkubo A; Yonezawa T; Nagai K
    Rinsho Ketsueki; 1987 Oct; 28(10):1729-37. PubMed ID: 3133506
    [No Abstract]   [Full Text] [Related]  

  • 15. [Tricuspid regurgitation evaluated by intraoperative epicardial pulsed Doppler echocardiography: investigation of patients with combined valvular diseases].
    Iida K; Hibi N; Takashina Y; Kambe T; Nakao M; Ieda N; Miyajima K; Nishida T; Tanaka M; Abe T
    J Cardiol; 1987 Dec; 17(4):797-806. PubMed ID: 3506606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gabexate mesilate (FOY) therapy of disseminated intravascular coagulation due to sepsis.
    Taenaka N; Shimada Y; Hirata T; Nishijima MK; Takezawa J; Yoshiya I; Kambayashi J
    Crit Care Med; 1983 Sep; 11(9):735-8. PubMed ID: 6411432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thoracic aortic aneurysm with chronic disseminated intravascular coagulation treated successfully with orally administered camostat mesilate, warfarin and aspirin].
    Fukuda N; Shimohakamada Y; Nakamori Y; Tominaga T; Shinohara K; Takahashi T; Oeda E; Sato Y
    Rinsho Ketsueki; 2002 Mar; 43(3):199-203. PubMed ID: 11979753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abdominal aortic aneurysm complicated with chronic disseminated intravascular coagulopathy: a case of surgical treatment.
    Mukaiyama H; Shionoya S; Ikezawa T; Kamiya T; Hamaguchi M; Saito H
    J Vasc Surg; 1987 Dec; 6(6):600-4. PubMed ID: 3121870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of disseminated intravascular coagulation].
    Asakura H
    Rinsho Ketsueki; 1990 Jun; 31(6):756-62. PubMed ID: 2214166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of pre-disseminated intravascular coagulation state with gabexate mesilate (FOY)].
    Wada H; Suzuki H; Deguchi A; Mori Y; Okubo I; Tsuda M; Nagano T; Deguchi K; Shirakawa S
    Rinsho Ketsueki; 1986 Dec; 27(12):2243-8. PubMed ID: 3106677
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.